title: A man with pleural effusion and ascites.
abstract: A male lifelong nonsmoker aged 58 years with no prior asbestos exposure complained of gradual worsening breathlessness over 3 months. This was associated with abdominal and leg swelling and a 2-kg weight loss. He had no fever, night sweats, hemoptysis, joint pain, rash, abdominal pain, chest pain, or orthopnea. The patient had no recent travel or contact with pulmonary TB. He had stage I left-side testicular seminoma treated with left-sided radical orchidectomy 10 years previous and recently received a diagnosis of Child's B alcoholic liver cirrhosis. His hepatitis B and C screen result was normal.
authors.affiliation: Division of Respiratory and Critical Care Medicine, National University Hospital, Singapore. Electronic address: andrew_yunkai_li@nuhs.edu.sg.
authors.forename: Andrew
authors.initials: A
authors.lastname: Li
authors.affiliation: Department of Haematology-Oncology, National University Cancer Institute of Singapore, Singapore.
authors.forename: Limei
authors.initials: L
authors.lastname: Poon
authors.affiliation: Division of Respiratory and Critical Care Medicine, National University Hospital, Singapore.
authors.forename: Kay-Leong
authors.initials: KL
authors.lastname: Khoo
authors.affiliation: Department of Pathology, National University Hospital, Singapore.
authors.forename: Ju-Ee
authors.initials: JE
authors.lastname: Seet
authors.affiliation: Department of Diagnostic-Imaging, National University Hospital, Singapore.
authors.forename: Arvind Kumar
authors.initials: AK
authors.lastname: Sinha
authors.affiliation: Division of Respiratory and Critical Care Medicine, National University Hospital, Singapore.
authors.forename: Pyng
authors.initials: P
authors.lastname: Lee
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001201:Ascites / Q000175:diagnosis* / Q000209:etiology*; D001402:B-Lymphocytes / Q000276:immunology / Q000473:pathology; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D019288:Herpesvirus 8, Human; D006801:Humans; D054685:Lymphoma, Primary Effusion / Q000150:complications* / Q000175:diagnosis* / Q000821:virology; D008297:Male; D008875:Middle Aged; D010996:Pleural Effusion / Q000175:diagnosis* / Q000209:etiology*; D011092:Polyethylene Glycols / Q000627:therapeutic use; D049268:Positron-Emission Tomography; D011994:Recombinant Proteins / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D011092:Polyethylene Glycols; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; C423652:pegylated granulocyte colony-stimulating factor